Welcome to the Radboud Institute for Health Sciences what are you looking for?
Kit Roes's research group aims to continuously improve the quality of medical research, by applying, teaching and developing statistical methods and statistical thinking, aiming for broad use by researchers.
Bart Kiemeney's research group learns as much as possible about cancer with the aim of reducing the burden of this disease. The emphasis lies on the detection of urological tumours and their genetic causes.
Mireille Broeders's research (sub)group looks at whether there’s value to be gained in targeting the screening or follow-up policy to a person’s level of risk, by collecting information on risk factors from screening participants and patients.
Dick Thijssen's research group focuses on the field of cardiovascular physiology and physical (in)activity. His work strongly focuses on understanding the impact of exercise training and physical activity on reducing the risk of developing cardiovascular and metabolic diseases.
Nielka van Erp's research group aims to optimize anticancer treatment in oncology patients by recognizing and addressing interindividual differences and by developing approaches to keep the drugs available for all patients suffering from cancer.
Saskia de Wildt's research group uses innovative methods including microdosing and microtracer technology, and physiology-based and population pharmacokinetic modeling, to contribute to a better understanding of the impact of age, disease and genetics on drug disposition in children.
Maroeska Rovers's research (sub)group investigates which surgical techniques are being used and whether or not they are necessary.
Thijs Eijsvogels’s research group studies the acute and long-term effects of exercise on health. Current projects involve cardiac imaging following lifelong exercise training, optimizing cardiac rehab, assessing thermoregulatory responses in elite athletes and development of cooling strategies.
Rob Baltussen's research (sub)group supports decision-makers in countries around the world in setting legitimate priorities for universal health coverage.
Gert Jan van der Wilt's research group conducts research into the effectiveness, safety, efficiency and social acceptability of medical technology.
Maroeska Rovers's research (sub)group aims to guide new medical technology innovations by facilitating partnerships between the scientific community, medical technology business partners and policy makers.
Cornelis (Kees) Kramers's research group aims to improve medication safety by education of prescribers, transmural interventions and medication optimization.
Nico Verdonschot's research group focuses on the external loads applied to the musculoskeletal system, and how these loads influence the reconstructions.
Bart van den Bemt's research group is a (inter)nationally recognized group on adequate medication use, medication adherence, medication waste and (cost-)effective pharmacotherapy.
Marieke Coenen's research group performs pharmacogenetic research, from gene-finding to clinical implementation studies with a focus on paediatric (oncology) and psychiatry and inflammatory bowel disease.
Roger Brüggemann's and Nynke Jager's research group investigates the pharmacokinetics and dynamics of antimicrobial agents. Research ranges from in vitro experiments to clinical trials in special patient populations. The main aim is to define the optimal dose for each individual patient.
Rob Aarnoutse's research group investigates the pharmacology of existing and new drugs for tuberculosis, using a translational approach that extends from molecular pharmacology to clinical pharmacology studies and to clinical trials, supported by advanced laboratory and modeling techniques.
David Burger's group investigates the pharmacology of antiviral drugs for the treatment of HIV and hepatitis C in special patient population such as pregnant women, children and hepatically impaired patients. We also study drug-drug interactions and the impact on exposure of new drug-formulations.
Dietmar Ulrich's research group is continuously aiming to find the latest and best methods to treat patients that visit the department of Plastic Surgery.
Rob ter Heine's and Elin Svensson's research group develops and applies mathematical models describing clinical pharmacology processes to interpret clinical trial data, perform clinical trial simulations, support drug development decisions, and optimize therapy in the clinic.
Nel Roeleveld's research group investigates all aspects of human reproduction. The primary question underlying our research is: how can we prevent something from going wrong before, during or after pregnancy?
Pim Assendelft's research group aims to improve healthcare, from a primary care and transmural perspective.
Paul Scheepers's research (sub)group investigates how we can stay healthy and which environmental factors affect our health.
Merel Ritskes-Hoitinga's research (sub)group aims to increase the value and reduce the waste of research in animal studies.
Gerard Rongen's research group studies the impact of nucleoside transport inhibitors on vascular actions of adenosine and ischemia reperfusion injury.
Daniele Tauriello's, Henk Verheul's, Nielka van Erp's and Iris Nagtegaal's research group is a cross-disciplinary research collaboration of four Radboudumc groups, with the aim of advancing clinical translation for colorectal cancer.
Reinout van Crevel's research group integrates patient studies and laboratory sciences to understand the biology of tuberculosis (TB) transmission, infection and disease, including its severest form: meningitis.
Have you noticed this button? Use this button to save, print or share.
This website uses cookies. Read more about cookies.